Stay updated with breaking news from Exene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has earned an average recommendation of “Buy” from the nine analysts that are currently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have issued ratings on the stock in […] ....
Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $65.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 52.19% from the company’s current […] ....
China Universal Asset Management Co. Ltd. boosted its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 417.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,546 shares of the biopharmaceutical company’s stock after buying an additional […] ....
SG Americas Securities LLC reduced its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 67.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,606 shares of the biopharmaceutical company’s stock after selling 38,146 shares during the quarter. SG […] ....
Polar Capital Holdings Plc reduced its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 0.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,003,747 shares of the biopharmaceutical company’s stock after selling 18,324 shares during the period. Polar […] ....